Get started
Author

Alex Yang

Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia
2014 · Mikhail Kosiborod, Henrik S. Rasmussen, et al. · JAMA · 423
Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function
2015 · Jiacong Luo, Steven M. Brunelli, et al. · Clinical Journal of the American Society of Nephrology · 294
Characterization of Structure and Function of ZS-9, a K+ Selective Ion Trap
2014 · Fiona Stavros, Alex Yang, et al. · PLoS ONE · 190
PDF
Maintenance of Serum Potassium with Sodium Zirconium Cyclosilicate (ZS-9) in Heart Failure Patients: Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
2015 · Stefan D. Anker, Mikhail Kosiborod, et al. · European Journal of Heart Failure · 184
PDF
Transitional dialysis care units: A new approach to increase home dialysis modality uptake and patient outcomes
2017 · José A. Morfín, Alex Yang, et al. · Seminars in Dialysis · 51
Improving Incident ESRD Care Via a Transitional Care Unit
2018 · Brendan Bowman, Sijie Zheng, et al. · American Journal of Kidney Diseases · 47
Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjects
2017 · Daniel Saltzstein, Neal D. Shore, et al. · Therapeutic Advances in Urology · 27
PDF
Polymer‐delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open‐label studies in patients with advanced prostate cancer
2016 · Neal D. Shore, Franklin Chu, et al. · British Journal of Urology · 19
PDF
Thermodynamic energy stability and in vitro potassium exchange capacity of ZS-9, a novel selective cation trap for the treatment of hyperkalemia
2014 · Alex Yang, Alejandro Leon, et al. · Journal of the American Society of Hypertension · 6
Fo012normalization of Serum Bicarbonate With Sodium Zirconium Cyclosilicate (zs-9) in the Phase 3 Randomized, Double-blind, Placebo-controlled Harmonize Study
2015 · Angel de Francisco, Henrik Rasmussen, et al. · Nephrology Dialysis Transplantation · 4
Nursing home care. Daily HHD vs conventional dialysis: A survival comparison.
2017 · Alex Yang, Annette Lee, et al. · PubMed · 3
Survival comparison of daily home hemodialysis vs. conventional in the nursing home setting.
2015 · Alex Yang, Wen-ya Lee, et al. · PubMed · 3
Acute-phase Efficacy of Zs-9 in Patients With Baseline Serum Potassium Levels Above 5.5 Meq/l: Analysis From a Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Trial
2015 · Mohamed El-Shahawy, Henrik S. Rasmussen, et al. · Journal of the American College of Cardiology · 2
PDF
Zs-9 Maintains Normokalemia in Hyperkalemic Patients Despite Continuing Raas Inhibitors: a Subgroup Analysis From a Phase 3 Multicenter, Randomized, Double Blind, Placebo-controlled Trial
2015 · Wajeh Qunibi, Henrik S. Rasmussen, et al. · Journal of the American College of Cardiology · 2
PDF
Treatment of Hyperkalemia With Zs-9, a Selective Nonabsorbed Cation Exchange Resin, Does Not Lead to Hypomagnesemia: Results From Two Multicenter, Randomized, Double Blind, Placebo-controlled Phase 3 Trials
2015 · Mohamed A. El-Shahawy, Henrik S. Rasmussen, et al. · Journal of the American College of Cardiology · 2
PDF
Perceived status of patient care technician training and certification impact in U.S. hemodialysis facilities.
2014 · Sally Burrows-Hudson, Jean Kammerer, et al. · PubMed · 2
Effect of ZS-9, a novel selective cation trap, on urinary potassium and sodium excretion when used for the treatment of hyperkalemia in patients with chronic kidney disease
2014 · Bhupinder Singh, Stephen R. Ash, et al. · Journal of the American Society of Hypertension · 2
Zs-9, a Novel Selective Cation Trap, Leads to a Rapid and Predictable Rate of Decline in Serum Potassium in Patients With Chronic Kidney Disease and Hyperkalemia
2014 · Bhupinder Singh, Stephen A. Ash, et al. · Journal of the American College of Cardiology · 2
PDF
An updated review: Health outcomes in nursing home patients on dialysis.
2016 · Alex Yang, Meng-Hsuan Lee, et al. · PubMed · 1
Fp008achievement of Normal Serum Potassium With Sodium Zirconium Cyclosilicate (zs-9) in a Subgroup of Patients With Stage 4/5 Chronic Kidney Disease and Baseline Potassium ≥5.5 Mmol/l From the Phase 3 Randomized, Double-blind, Placebo-controlled Harmonize Study
2015 · Simon D. Roger, Angel de Francisco, et al. · Nephrology Dialysis Transplantation · 1
Fp001effect of Sodium Zirconium Cyclosilicate (zs-9) on Urinary Potassium and Sodium: an Analysis of the Phase 3 Randomized, Double-blind, Placebo-controlled Harmonize Study
2015 · Michel Jadoul, Henrik Rasmussen, et al. · Nephrology Dialysis Transplantation · 1
Fp003achievement and Maintenance of Normokalaemia in Patients With Non-dialysis Stage 5 Chronic Kidney Disease
2015 · Angel de Francisco, Henrik Rasmussen, et al. · Nephrology Dialysis Transplantation · 1
Fp007efficiency of Sodium Zirconium Cyclosilicate (zs-9) Increases With Severity of Hyperkalaemia: Subgroup Analysis of Patients Stratified by Baseline Potassium in the Phase 3 Harmonize Study
2015 · Johannes Mann, Henrik Rasmussen, et al. · Nephrology Dialysis Transplantation · 1
Fp010maintenance of Normal Serum Potassium With Sodium Zirconium Cyclosilicate (zs-9) in Subgroup of Patients With History of Chronic Kidney Disease and on Raas Inhibitors From the Phase 3 Randomized, Double-blind, Placebo-controlled Harmonize Study
2015 · David Packham, Henrik Rasmussen, et al. · Nephrology Dialysis Transplantation · 1
ZS-9 once-daily maintained serum K+ in hyperkalemic subjects on RAAS therapy: subgroup analysis from a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
2014 · Bhupinder Singh, Henrik S. Rasmussen, et al. · Journal of the American Society of Hypertension · 1
Works count: 52
Citation count: 1,272
H-index: 8
I10-index: 8
Year
Topic
Type